January 30, 2009Anti-Depressants Ranked Versus Other Anti-DepressantsA study came out in The Lancet the other day and I held off writing about it, waiting to see how the media would handle it. It was a very large meta study of anti-depressant trials where one anti-depressant was trialed against another anti-depressant. I don't have access to full text of Lancet studies, but from the abstract it's apparent that the authors didn't report how those anti-depressants performed versus placebo in all these trials--it's possible of course that none of these studies had placebo arms or that only some did and some of the drug v. drug trials are bound to be small since the whole meta study included 25,928 people in 117 trials. Anyway, I point this out because I am highly suspicious of studies of psych meds that don't include placebo arms, since I don't think you can learn much about the value of an individual med without controlling for the placebo effect. That's just me, of course. Feel free to have your own opinion. Just so folks know, I've taken six of these drugs and I pretty much hated them all. What's interesting is that none of the media coverage I saw mentioned the placebo matter, so you really have to wonder about global efficacy of the drugs. I've read loads of anti-depressant studies over the years and generally speaking you end up with a fairly sizeable placebo effect and an effect size for the drugs that runs from 12 percent to about 30 percent. But this study was about trying to help patients (I guess) and doctors sort out which of the 12 modern anti-depressants are best, compared with other drugs in their class. (The study didn't look at extended release version of Paxil and Wellbutrin.) The big winners were Zoloft and Lexapro, based upon their efficacy versus other anti-depressants and their tolerability versus other anti-depressants. The final nod went to Zoloft due to its being generic and inexpensive. With one exception, the researchers who authored this study had deep ties to pharma companies (see the above-linked abstract for disclosures). ABCnews.com kindly produced a list of the rankings: Efficacy: 1. Remeron Tolerability: 1. Zoloft Interestingly, I didn't catch any press coverage of this study that noted that Savella is not approved in the US as an anti-depressant, but was only recently approved as a fibromyalgia treatment in the US. As for Vestra, it is not approved for any use in the US and in fact in May 2007, the FDA shot down its maker's application for the US. Obviously the study was aimed at a global market, but for US media to not catch that it was ranking two drugs not available for depression in the US is very, very sloppy reporting (and makes me extra cranky that some of these folks are getting a journalism paycheck while I am not). What also interests me is the implicit assumption in the study and the press coverage that someone diagnosed with depression is going to head straight for the meds. That's just arrogant. It is amusing however to see how poorly Cymbalta performed on all measures. You've got to expect that, Eli Lilly being Eli Lilly, its maker will have its sales reps out in the field pronto to somehow try and defang the effects of this study. Posted by Philip Dawdy at January 30, 2009 12:01 AM
del.icio.us
Digg it
reddit
Comments
Boo hoo hoo to Lilly. And boo, hiss for even bothering with this study. C'mon Lancet, you can do better than this. Lexapro made my daughter suicidal/homicidal, in two days. Posted by: Sorrowful at January 31, 2009 11:08 PMPost a comment
|
Patient Blogs. Sites.
The Trouble With Spikol
Icarus Project Blog John's Bipolar Stories Seroxat (Paxil) Sufferers Stand Up! Seroxat (Paxil) Secrets The Bipolar View Writhe Safely soulful sepulcher Electro Boy Spiritual Emergency Mental Nurse Deborah Gray Mental Mommy The Splintered Mind bipolar.and.me Nurse Ratched Psych Person Trick Cycling for Beginners depression introspection Salted Lithium Living With A Purple Dog Polar Trippin' Mercurial Scribe Bipolar Chicks Blogging Beyond Meds Off Label Jung At Heart Graphic Truth Joysoup Apesma's Lament Soapy Water Outlaw Psychiatry Empirical Insanity Patient Anonymous Beyond Blue Psych Survivor Postpartum Progress The Happiness Project Finding Optimism The Gimp Parade Midlife and Treachery Secret Life of a Manic-Depressive Psych Tech Going Through Hell
Doctor Blogs. Sites.
Clinical Psych
World of Psychology CorePsych The Last Psychiatrist Carlat Report Blog Intueri Emotional Well-Being Scientific Misconduct Aaron Beck Cognitive Therapy Today Treatment Online Shrink Rap David Healy Dr. Dork NHS Blog Doctor Dr. X's Free Associations Dr. Sanity Anxious Mind Everyone Needs Therapy Counselling Resource
Activists. News.
Charlottesville Prejudice Watch
The Icarus Project MindFreedom AHRP Blog SSRI Stories Healthy Skepticism Psych Rights Treatment Advocacy Center Peter Breggin Schizophrenia News eDrugSearch Blog Nuts R Us News Disapedia WSJ Health Blog Alison Bass
Social Networking. Forums.
Beyond Meds Social Network
Mood Garden Paxil Progress Crazy Boards Forums Psych Central Forums Icarus Project Forums DepressionTribe MySpace Bipolar Group Bipolar World Pendulum.org Bipolar Planet About.com Bipolar
Science. Big Pharma. Ethics.
PharmaLot
Pharma Gossip Science Blogs Mind Hacks GoozNews Integrity in Science Neurophilospohy bioethics.net Drug Wonks Pharma Marketing Blog Pharma's Cutting Edge On Pharma Health Care Renewal
Current Affairs
Buzz Machine
To The People Andrew Sullivan Michelle Malkin Daily Kos Reason's Hit&Run The Agitator Press Think Jim Romenesko Rough Type Gawker The Graphic Truth Tail Rank Huffington Post Instapundit Little Green Footballs Talking Points Memo MoJo Blog
Seattle Stuff
Smoking. Stuff.
|

